Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Ingenito
Observed name:
M. Ingenito
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0009-0006-6737-7736
Observed ORCID:
0009-0006-6737-7736
OpenAlex ID:
A5114525070
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma
2025
·
Domenico Mallardo
, Mario Fordellone
, et al.
·
Journal for ImmunoTherapy of Cancer
·
10
PDF
Prognostic implications of glycemia in non-diabetic patients with metastatic melanoma undergoing immunotherapy.
2025
·
Domenico Mallardo
, Anita Minopoli
, et al.
·
Journal of Clinical Oncology
·
1
8P The role of glycemia in prognostic implications for non-diabetic melanoma patients treated with immunotherapy
2025
·
D. Mallardo
, A. Minopoli
, et al.
·
Immuno-Oncology Technology
PDF
1214 AI-derived histopathological features predict survival outcomes in advanced melanoma
2024
·
Gabriele Madonna
, Sid Gupta
, et al.
·
Journal for ImmunoTherapy of Cancer
Show more works
View as search
Works count:
4
Citation count:
11
H-index:
1
I10-index:
1
Year
Topic
Type